Amylyx Pharmaceuticals Inc (AMLX)
2.035
+0.04
(+1.75%)
USD |
NASDAQ |
May 03, 16:00
2.035
0.00 (0.00%)
After-Hours: 18:18
Amylyx Pharmaceuticals Price to Book Value: 0.3183 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 0.3128 |
| May 01, 2024 | 0.3018 |
| April 30, 2024 | 0.2831 |
| April 29, 2024 | 0.2971 |
| April 26, 2024 | 0.2752 |
| April 25, 2024 | 0.2784 |
| April 24, 2024 | 0.294 |
| April 23, 2024 | 0.305 |
| April 22, 2024 | 0.3096 |
| April 19, 2024 | 0.2924 |
| April 18, 2024 | 0.3096 |
| April 17, 2024 | 0.3128 |
| April 16, 2024 | 0.3143 |
| April 15, 2024 | 0.3237 |
| April 12, 2024 | 0.3284 |
| April 11, 2024 | 0.3581 |
| April 10, 2024 | 0.3847 |
| April 09, 2024 | 0.4175 |
| April 08, 2024 | 0.4207 |
| April 05, 2024 | 0.4097 |
| April 04, 2024 | 0.4082 |
| April 03, 2024 | 0.4113 |
| April 02, 2024 | 0.4097 |
| April 01, 2024 | 0.4238 |
| March 28, 2024 | 0.4441 |
| Date | Value |
|---|---|
| March 27, 2024 | 0.4504 |
| March 26, 2024 | 0.4285 |
| March 25, 2024 | 0.4238 |
| March 22, 2024 | 0.4285 |
| March 21, 2024 | 0.4488 |
| March 20, 2024 | 0.4645 |
| March 19, 2024 | 0.4582 |
| March 18, 2024 | 0.4473 |
| March 15, 2024 | 0.5067 |
| March 14, 2024 | 0.4957 |
| March 13, 2024 | 0.538 |
| March 12, 2024 | 0.538 |
| March 11, 2024 | 0.5943 |
| March 08, 2024 | 0.5255 |
| March 07, 2024 | 2.967 |
| March 06, 2024 | 2.979 |
| March 05, 2024 | 2.948 |
| March 04, 2024 | 2.993 |
| March 01, 2024 | 2.926 |
| February 29, 2024 | 2.948 |
| February 28, 2024 | 3.060 |
| February 27, 2024 | 2.971 |
| February 26, 2024 | 2.746 |
| February 23, 2024 | 2.760 |
| February 22, 2024 | 2.899 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2752
Minimum
Apr 26 2024
18.06
Maximum
Dec 01 2022
5.537
Average
3.998
Median
Price to Book Value Benchmarks
| Cassava Sciences Inc | 6.936 |
| iRhythm Technologies Inc | 15.13 |
| Bristol-Myers Squibb Co | 5.408 |
| Moderna Inc | 3.454 |
| ACADIA Pharmaceuticals Inc | 6.509 |
Price to Book Value Related Metrics
| PE Ratio | 2.907 |
| PS Ratio | 0.3744 |
| Price to Free Cash Flow | 13.35 |
| Price | 2.035 |
| Earnings Yield | 34.40% |
| Market Cap | 137.94M |
| Operating PE Ratio | 3.675 |
| Normalized PE Ratio | 2.907 |